Effect of Withania somnifera on cyclophosphamide-induced urotoxicity

Cancer Letters

Volumn 148, Issue 1, 2000, Pages 9-17

  Davis, Leemol ^a   Kuttan, Girija ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

Cyclophosphamide; Histopathology; Urotoxicity

Indexed keywords

CYCLOPHOSPHAMIDE; GLUTATHIONE; MESNA; PLASMA PROTEIN; WITHANIA SOMNIFERA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER INJURY; CONTROLLED STUDY; DRUG ANTAGONISM; HISTOPATHOLOGY; INFLAMMATION; LIVER; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; TISSUE LEVEL; TISSUE NECROSIS; UREA NITROGEN BLOOD LEVEL; URINARY TRACT INJURY;

ANIMALS; BLOOD PROTEINS; CYCLOPHOSPHAMIDE; GLUTATHIONE; INFLAMMATION; LIVER; MICE; NITROGEN; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; SOLANACEAE; UREA; URINARY BLADDER; URINARY BLADDER DISEASES;

ANIMALIA; SOLANACEAE; WITHANIA; WITHANIA SOMNIFERA;

EID: 0033989964     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00252-9     Document Type: Article

References (18)

1. Colvin M., Brundett R.B., Kunmn K. Alkylating properties of phosphamide mustard. Cancer. 36:1976;112.
2. Lobnnsh N.L., Gerrard J.M., Watson M. Shortening of bleeding time by 1-deamino 8-D-arginine vasopressin in various bleeding disorders. Lancet. 1:1986;1145-1148.
3. Sahni Y.P., Srivastava D.N., Parassar G.C. Involvement of mediators of pain in analgestic activity of Withania somnifera. Indian Vet. J. 72:(10):1995;1035-1039.
4. Al Hindawi M.K., Al Khafavi S.H., Abdul Nabi M.H. Antigranuloma activity of Iraqi Withania somnifera. J. Ethanopharamacol. 37:(2):1993;113-116.
5. Nashine K., Srivastava D.N., Sahini Y.P. Role of inflammatory mediators in anti-inflammatory activity of Withania somnifera. Indian Vet. Med. J. 19:(4):1995;286-288.
6. Sahni Y.P., Srivastava D.N. Role of inflammatory mediators in anti-inflammatory activity of Withania somnifera on chronic inflammatory reaction. Indian Vet. Med. J. 19:(2):1995;150-153.
7. Ziauddin M., Phansalkar N., Pattki P., Diwanay S., Patwardhan B. Studies on the immunomodulatory effect of Ashwagandha. J. Ethanopharmacol. 50:(2):1996;69-76.
8. Kuttan G. Use of Withania somnifera as an adjuvant during radiation therapy. Indian J. Exp. Biol. 1996;854-856.
9. Sbohat B., Gitter S., Lavie D. Effect of Withaferin A on Ehrlisch ascites tumour cells. Cytological observations. Int. J. Cancer. 5:1970;244-252.
10. Devi P.U., Sharada A.C., Solomon F.E. In vivo growth inhibitory and radiosenstizing effect of Withaferin A on mouse Ehrlisch ascites carcinoma. Cancer Lett. 95:(1-2):1995;189-193.
11. Sharada A.C., Solomon F.E., Devi P.U., Udupa N., Srinivasan K.K. Antitumour and radiosensitizing effect of Withaferin A on mouse Ehrlisch ascites carcinoma in vivo. Acta Oncologica. 35:(11):1996;95-100.
12. Das H., Dutta S.K., Bhattacharya B., Chakraborti S.K. Antineoplastic agents from plants. Antitumour activities of Withanolide D. Indian J. Cancer Chemother. 7:1985;59-65.
13. Moron M.A., De Pierre J.W., Mannerrick B. Levels of glutathione-S-transferase activities in rat liver. Biochim. Biophys. Acta. 582:1979;67-68.
14. Bishel M.D. CTX haemorrhagic cystitus following prolonged low dose therapy. J. Am. Med. Assoc. 20:1979;238.
15. Javadpour N., Burakat H.A. Bladder toxicity due to CTX. Urology. 2:1973;634.
16. Coleman C.N., Bump E.A., Kramer R.A. Chemical modifiers of cancer therapy. J. Clin. Oncol. 6:1988;709-733.
17. Arrick B.A., Nathan C.F. Glutathione metabolism as a determinant of therapeutic efficacy. Ann. Rev. Cancer Res. 40:1984;4224-4232.
18. Carmichael J., Adams D.J., Ansell J. Glutathione and glutathione transferase levels in mouse granulocyte following CTX administration. Cancer Res. 46:1986;735-739.